Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Blood Advances
Published September 16, 2026
T-cell dynamics, CD8/NK ratio and tumor survival hallmarks determine response to T-cell bispecifi...
September 17, 2026
Medspoke
Medspoke
The Lancet Haematology
Published September 16, 2026
00:00
--:--
Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised,...
September 17, 2026
Share
Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial.
https://www.medspoke.co/channel_playlist?object_id=123&tap_id=14083
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Leukemia
Published September 16, 2026
Clinical evaluation of AI-assisted quantitative marrow fibrosis assessment using Continuous Index...
September 17, 2026
Why are you reporting this TALK?
